Stem Cells and Their Derivatives in Cardiac Fibrosis Therapy: Challenges and Perspectives

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Biotechnology

Background:

• Cardiac fibrosis is a common abnormality linked to myocardial infarction and cardiomyopathies.
• It involves excessive extracellular matrix accumulation, leading to impaired heart function and arrhythmias.
• Current treatments mainly slow fibrosis progression.

Purpose of the Study:

• To review recent advancements in stem cell-based therapies for cardiac fibrosis.
• To explore cell types, implementation methods, and optimization strategies.
• To highlight the potential of exosomes in treating cardiac diseases.

Main Methods:

• Systematic review of recent scientific literature.
• Focus on stem cell derivatives and their therapeutic applications.
• Analysis of exosome-based strategies for cardiac fibrosis treatment.

Main Results:

• Stem cell therapies demonstrate potential in reducing cardiac fibrosis formation and area.
• Exosomes are identified as promising tools for innovative cardiac disease treatment.
• Various cell types and implementation methods are being explored for efficacy.

Conclusions:

• Stem cell-derived therapies offer a promising avenue for mitigating cardiac fibrosis.
• Exosomes represent a novel and effective therapeutic strategy for cardiac conditions.
• Further research into optimizing these approaches is warranted for clinical translation.